Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Genetic toxicity in vitro

Description of key information
No mutagenic effects were found in the assay in mammalian Mouse-Lymphoma cells in vitro.
Link to relevant study records
Reference
Endpoint:
in vitro gene mutation study in mammalian cells
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2005
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: current guideline study according to GLP
Qualifier:
according to guideline
Guideline:
OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
Deviations:
no
GLP compliance:
yes
Type of assay:
mammalian cell gene mutation assay
Target gene:
autosomal thymidine kinase (TK) locus
Species / strain / cell type:
mouse lymphoma L5178Y cells
Metabolic activation:
with and without
Metabolic activation system:
Phenobarbital/b-Naphthoflavone induced rat liver S9 was used as the metabolic activation system. The S9 was prepared from 8 - 12 weeks old male Wistar HanIbm rats.
Test concentrations with justification for top dose:
Experiment I
without S9 mix: 11.3; 22.5; 45.0; 90.0 and 180.0 μg/mL
with S9 mix: 11.3; 22.5; 45.0; 90.0 and 180.0 μg/mL
Experiment II
without S9 mix: 11.3; 22.5; 45.0; 90.0 and 180.0 μg/mL
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: DMSO;
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
Positive controls:
yes
Positive control substance:
cyclophosphamide
methylmethanesulfonate
Details on test system and experimental conditions:
METHOD OF APPLICATION: in medium;

DURATION
- Exposure duration:4 (with S9) or 24 hours (without S9)
- Expression time (cells in growth medium): 72 h; 48 h in the second experiment
- Selection time (if incubation with a selection agent): 10 - 15 days

SELECTION AGENT (mutation assays): TFT (trifluorothymidine)

DETERMINATION OF CYTOTOXICITY
- Method: relative total growth, cloning effieciency
Statistics:
A mutation assay is considered acceptable if it meets the following criteria:
a) Both plates, from either the survival or the TFT resistance-testing portion of the experiment are analysable.
b) The absolute cloning efficiency 2 of the negative and/or solvent controls is > 0.5 (50 %).
c) The spontaneous mutant frequency in the negative and/or solvent controls are in the range of our historical control data.
d) The positive controls (MMS and CPA) induce significant (at least 2-fold) increases in the mutant frequencies. The values of the cloning efficiencies and the relative total growth are greater than 10 % of the concurrent vehicle control group.
Species / strain:
mouse lymphoma L5178Y cells
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity, but tested up to precipitating concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid

 

Culture 1

Culture 2

 

µg/mL

S9

Rel cloning effic.

Rel. total growth

Mutant colonies /106cells

Induction factor

Rel cloning effic.

Rel. total growth

Mutant colonies /106cells

Induction factor

Experiment 1

Medium control

0

-

100.0

100.0

49

 

100.0

100.0

79

 

Solvent Control

0

-

100

100

54

1,0

100

100

42

1,0

MMS

19,5

-

50,0

17,5

672

13,6

33,3

23,0

716

9,0

Test item

5,7

-

73,6

discontinued

116,1

discontinued

Test item

11,3

-

100

73,4

136

2,5

105,5

132,2

22

0,5

Test item

22,5

-

71,1

120,0

39

0,7

83,5

86,8

28

0,7

Test item

45

-

93,1

99,2

68

1,3

86,2

86,6

78

1,8

Test item

90 (p)

-

73,6

124,7

54

1,0

113,8

92,1

30

0,7

Test item

180 (p)

-

87,8

126

47

0,9

91,9

92,6

45

1,1

 

Medium control

 

+

100

100

53

 

100

100

55

 

Solvent Control

 

+

100

100

57

1

100

100

55

1

CPA

3,0

+

93,5

57,5

333

6,3

65,9

80,2

314

5,7

Test item

5,7

+

70,7

discontinued

87,4

discontinued

Test item

11,3

+

113,7

157,3

32

0,6

86,0

112,0

27

0,5

Test item

22,5

+

70,7

139,3

39

0,7

109,6

95,2

40

0,7

Test item

45

+

113,7

145,8

43

0,8

88,8

96,6

53

1,0

Test item

90 (p)

+

51,3

152,3

47

0,8

83,3

105,3

37

0,7

Test item

180 (p)

+

87,8

171,6

44

0,8

80,8

60,7

57

1,0

Experiment 2

Medium control

 

-

100

100

48

 

100

100

45

 

Solvent Control

 

-

100

100

48

1,0

100

100

41

1,0

MMS

13,0

-

67,6

56,6

314

6,5

31

58,2

296

6,6

Test item

5,7

-

114,7

discontinued

108,6

discontinued

Test item

11,3

-

102,1

122,1

42

0,9

127,9

134

40

1,0

Test item

22,5

-

58,6

125,2

43

0,9

52,6

176

38

0,9

Test item

45

-

111,9

119,6

44

0,9

93,9

92,5

33

0,8

Test item

90 (p)

-

117,7

95

45

0,9

123,1

121,1

45

1,1

Test item

180 (p)

-

109,3

150,1

38

0,8

155,9

126,8

58

1,4

 

Conclusions:
Interpretation of results (migrated information):
negative

The test material is considered to be non-mutagenic in this mouse lymphoma
assay.
Executive summary:

The study was performed to investigate the potential of the test material to induce mutations at the mouse lymphoma thymidine kinase locus using the cell line L5178Y.

The assay was performed in two independent experiments, using two parallel cultures each. The first main experiment was performed with and without liver microsomal activation and a treatment period of 4 h. The second experiment was solely performed in the absence of metabolic activation with a treatment period of 24 hours.

The highest applied concentration (180 μg/mL) was limited by the solubility properties of the test item.

No substantial and reproducible dose dependent increase in mutant colony numbers was observed in both main experiments. No relevant shift of the ratio of small versus large colonies was observed up to the maximal concentration of the test item.

Appropriate reference mutagens were used as positive controls and showed a distinct increase in induced mutant colonies, indicating that the tests were sensitive and valid.

The tested concentrations were:

Experiment I

without S9 mix: 11.3; 22.5; 45.0; 90.0 and 180.0 μg/mL

with S9 mix: 11.3; 22.5; 45.0; 90.0 and 180.0 μg/mL

Experiment II

without S9 mix: 11.3; 22.5; 45.0; 90.0 and 180.0 μg/mL

The evaluated experimental points and the results are summarised in table:

 

Culture 1

Culture 2

 

µg/mL

S9

Rel cloning effic.

Rel. total growth

Mutant colonies /106cells

Induction factor

Rel cloning effic.

Rel. total growth

Mutant colonies /106cells

Induction factor

Experiment 1

Medium control

0

-

100.0

100.0

49

 

100.0

100.0

79

 

Solvent Control

0

-

100

100

54

1,0

100

100

42

1,0

MMS

19,5

-

50,0

17,5

672

13,6

33,3

23,0

716

9,0

Test item

5,7

-

73,6

discontinued

116,1

discontinued

Test item

11,3

-

100

73,4

136

2,5

105,5

132,2

22

0,5

Test item

22,5

-

71,1

120,0

39

0,7

83,5

86,8

28

0,7

Test item

45

-

93,1

99,2

68

1,3

86,2

86,6

78

1,8

Test item

90 (p)

-

73,6

124,7

54

1,0

113,8

92,1

30

0,7

Test item

180 (p)

-

87,8

126

47

0,9

91,9

92,6

45

1,1

 

Medium control

 

+

100

100

53

 

100

100

55

 

Solvent Control

 

+

100

100

57

1

100

100

55

1

CPA

3,0

+

93,5

57,5

333

6,3

65,9

80,2

314

5,7

Test item

5,7

+

70,7

discontinued

87,4

discontinued

Test item

11,3

+

113,7

157,3

32

0,6

86,0

112,0

27

0,5

Test item

22,5

+

70,7

139,3

39

0,7

109,6

95,2

40

0,7

Test item

45

+

113,7

145,8

43

0,8

88,8

96,6

53

1,0

Test item

90 (p)

+

51,3

152,3

47

0,8

83,3

105,3

37

0,7

Test item

180 (p)

+

87,8

171,6

44

0,8

80,8

60,7

57

1,0

Experiment 2

Medium control

 

-

100

100

48

 

100

100

45

 

Solvent Control

 

-

100

100

48

1,0

100

100

41

1,0

MMS

13,0

-

67,6

56,6

314

6,5

31

58,2

296

6,6

Test item

5,7

-

114,7

discontinued

108,6

discontinued

Test item

11,3

-

102,1

122,1

42

0,9

127,9

134

40

1,0

Test item

22,5

-

58,6

125,2

43

0,9

52,6

176

38

0,9

Test item

45

-

111,9

119,6

44

0,9

93,9

92,5

33

0,8

Test item

90 (p)

-

117,7

95

45

0,9

123,1

121,1

45

1,1

Test item

180 (p)

-

109,3

150,1

38

0,8

155,9

126,8

58

1,4

 

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (negative)

Additional information

Additional information from genetic toxicity in vitro:

Depending on the purity of the tested sample several tests in bacteria gave conflicting results. However, the higher quality studies with better characteriszed samples gave negative results in the Ames test. Negative results were also found in the assay in mammalian Mouse-Lymphoma cells in vitro.


Justification for selection of genetic toxicity endpoint
The mammalian cell test is the most relevant of the available studies

Justification for classification or non-classification

No Classification

The available valid data do not indicate a mutagenic hazard.